Meier F - Search Results

1

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.

Gaißler A, Meldgaard TS, Heeke C, Babaei S, Tvingsholm SA, Bochem J, Spreuer J, Amaral T, Wagner NB, Klein R, Meier F, Garbe C, Eigentler TK, Pawelec G, Claassen M, Weide B, Hadrup SR, Wistuba-Hamprecht K. Gaißler A, et al. Among authors: meier f. Front Immunol. 2022 Jul 7;13:906352. doi: 10.3389/fimmu.2022.906352. eCollection 2022. Front Immunol. 2022. PMID: 35874702 Free PMC article.

2

Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations.

Schlagenhauff B, Stroebel W, Ellwanger U, Meier F, Zimmermann C, Breuninger H, Rassner G, Garbe C. Schlagenhauff B, et al. Among authors: meier f. Cancer. 1997 Jul 1;80(1):60-5. doi: 10.1002/(sici)1097-0142(19970701)80:1<60::aid-cncr8>3.0.co;2-j. Cancer. 1997. PMID: 9210709

3

Molecular events in melanoma development and progression.

Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, Herlyn M. Meier F, et al. Front Biosci. 1998 Sep 15;3:D1005-10. doi: 10.2741/a341. Front Biosci. 1998. PMID: 9740553 Review.

4

Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C. Schittek B, et al. Among authors: meier f. Nat Immunol. 2001 Dec;2(12):1133-7. doi: 10.1038/ni732. Nat Immunol. 2001. PMID: 11694882

5

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.

Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C. Meier F, et al. Br J Dermatol. 2002 Jul;147(1):62-70. doi: 10.1046/j.1365-2133.2002.04867.x. Br J Dermatol. 2002. PMID: 12100186

6

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, Schlagenhauff B, Meier F, Schittek B, Blaheta HJ, Blum A, Rassner G. Garbe C, et al. Among authors: meier f. J Clin Oncol. 2003 Feb 1;21(3):520-9. doi: 10.1200/JCO.2003.01.091. J Clin Oncol. 2003. PMID: 12560444

7

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.

Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B. Garbe C, et al. Among authors: meier f. Cancer. 2003 Apr 1;97(7):1737-45. doi: 10.1002/cncr.11250. Cancer. 2003. PMID: 12655531 Free article.

8

The natural course of cutaneous melanoma.

Leiter U, Meier F, Schittek B, Garbe C. Leiter U, et al. Among authors: meier f. J Surg Oncol. 2004 Jul 1;86(4):172-8. doi: 10.1002/jso.20079. J Surg Oncol. 2004. PMID: 15221923 Review.

9

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.

Meier F, Schittek B, Busch S, Garbe C, Smalley K, Satyamoorthy K, Li G, Herlyn M. Meier F, et al. Front Biosci. 2005 Sep 1;10:2986-3001. doi: 10.2741/1755. Front Biosci. 2005. PMID: 15970553 Review.

10

The adhesion molecule L1 (CD171) promotes melanoma progression.

Meier F, Busch S, Gast D, Göppert A, Altevogt P, Maczey E, Riedle S, Garbe C, Schittek B. Meier F, et al. Int J Cancer. 2006 Aug 1;119(3):549-55. doi: 10.1002/ijc.21880. Int J Cancer. 2006. PMID: 16506207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,001 results

Search Page

Filters